No Data
Gongdong Medical: 2024 Annual Results Advance Announcement
Zhejiang Gongdong Medical Technology (605369.SH): Net income is expected to increase by approximately 60.37% in 2024.
Gelonghui, January 22nd丨Zhejiang Gongdong Medical Technology (605369.SH) announced the preliminary performance forecast for 2024. According to initial calculations by the finance department, the company expects to achieve a Net income of approximately 175 million yuan attributable to the shareholders of the listed company in 2024, representing a year-on-year increase of about 60.37%. The company also anticipates a Net income of about 173.24 million yuan attributable to the shareholders of the listed company, excluding non-recurring gains and losses, in 2024, representing a year-on-year increase of approximately 60.91%. The company focuses on customized Business for overseas major clients and strengthens the development of business with leading clients in the Global in-vitro diagnostic Industry.
Zhejiang Gongdong Medical Technology (605369.SH): Plans to launch the first phase of its employee stock ownership plan.
Gelonghui, December 11丨 Zhejiang Gongdong Medical Technology (605369.SH) announced the first phase of its employee stock ownership plan, which, after being reviewed and approved by the company's shareholders' meeting, will acquire and Hold the company's shares held in the company's repurchase special securities Account through non-transaction transfers and other methods permitted by laws and regulations, totaling no more than 1 million shares, accounting for 0.63% of the company's current total share capital. Among them, the initial transfer will be 892,600 shares, accounting for 89.26% of the total number of stocks in this employee stock ownership plan; reserving 107,400 shares, accounting for 10.74% of the total number of stocks in this employee stock ownership plan.
Zhejiang Gongdong Medical Technology (605369.SH): Completed the renewal of the medical instruments production license.
Great Wisdom Report, November 13th | Zhejiang Gongdong Medical Technology (605369.SH) announced that it has recently obtained the "Medical Instruments Production License" reissued by the Zhejiang Provincial Drug Administration, this change is an extension of the license period. The extension of the "Medical Instruments Production License" this time is based on the business needs of the company.
Gongdong Healthcare: Third Quarter Report 2024
Zhejiang Gongdong Medical Technology (605369.SH): The net income for the first three quarters was 0.141 billion yuan, a year-on-year increase of 60.22%.
Gongdong Medical Technology (605369.SH) released the third quarter report for 2024 on October 29. The company's revenue for the first three quarters of the year was 0.836 billion yuan, a year-on-year increase of 17.31%; the net income attributable to shareholders of listed companies was 0.141 billion yuan, a year-on-year increase of 60.22%; the basic earnings per share was 0.90 yuan.
Here's What's Concerning About Zhejiang Gongdong Medical Technology's (SHSE:605369) Returns On Capital
